Cardiex Ltd - Asset Resilience Ratio
Cardiex Ltd (CDX) has an Asset Resilience Ratio of 0.16% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Cardiex Ltd's Asset Resilience Ratio has changed over time. Check CDX strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Cardiex Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CDX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$27.98K | 0.16% |
| Total Liquid Assets | AU$27.98K | 0.16% |
Asset Resilience Insights
- Limited Liquidity: Cardiex Ltd maintains only 0.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cardiex Ltd Industry Peers by Asset Resilience Ratio
Compare Cardiex Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Cardiex Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Cardiex Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 38.50% | AU$4.87 Million ≈ $3.45 Million |
AU$12.65 Million ≈ $8.95 Million |
-0.36pp |
| 2023-06-30 | 38.86% | AU$5.56 Million ≈ $3.93 Million |
AU$14.30 Million ≈ $10.12 Million |
+30.43pp |
| 2022-06-30 | 8.43% | AU$1.04 Million ≈ $738.22K |
AU$12.38 Million ≈ $8.76 Million |
-5.20pp |
| 2021-06-30 | 13.63% | AU$1.54 Million ≈ $1.09 Million |
AU$11.26 Million ≈ $7.97 Million |
+6.81pp |
| 2020-06-30 | 6.82% | AU$728.54K ≈ $515.49K |
AU$10.68 Million ≈ $7.55 Million |
+46.59pp |
| 2019-06-30 | -39.77% | AU$-5.25 Million ≈ $-3.72 Million |
AU$13.21 Million ≈ $9.35 Million |
-- |
| 2017-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$2.96 Million ≈ $2.09 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$4.60 Million ≈ $3.26 Million |
-- |
| 2003-06-30 | 0.97% | AU$15.00K ≈ $10.61K |
AU$1.54 Million ≈ $1.09 Million |
+0.01pp |
| 2002-06-30 | 0.96% | AU$15.00K ≈ $10.61K |
AU$1.56 Million ≈ $1.10 Million |
-- |
About Cardiex Ltd
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more